Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.

[1]  R. Thadhani,et al.  Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. , 2009, Journal of the American Society of Nephrology : JASN.

[2]  M. Olschewski,et al.  Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[3]  Holly Janes,et al.  Assessing the Value of Risk Predictions by Using Risk Stratification Tables , 2008, Annals of Internal Medicine.

[4]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[5]  Jane A. Linderbaum,et al.  ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Wr , 2008, Journal of the American College of Cardiology.

[6]  Maria Grazia Valsecchi,et al.  Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  J. Collins,et al.  Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply? , 2007, Nephrology.

[8]  W. Bennett.  Should dialysis patients ever receive warfarin and for what reasons? , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[9]  Silvia G Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit , 2006, Journal of the American College of Cardiology.

[10]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[11]  A. Yıldırır,et al.  Frequency of atrial fibrillation and factors related to its development in dialysis patients. , 2006, International journal of cardiology.

[12]  M. Valsecchi,et al.  Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  M. Josephson,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[14]  B. Gage,et al.  Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.

[15]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[16]  Feng Lin,et al.  The Incidence of End-Stage Renal Disease Is Increasing Faster than the Prevalence of Chronic Renal Insufficiency , 2004, Annals of Internal Medicine.

[17]  R. Wolfe,et al.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Journal of the American Society of Nephrology : JASN.

[18]  B. Kestenbaum,et al.  Elevated risk of stroke among patients with end-stage renal disease. , 2003, Kidney international.

[19]  E. Ritz,et al.  Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. , 2003, Kidney international.

[20]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[21]  Allen J. Taylor,et al.  Atrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality , 2003, BMC nephrology.

[22]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[23]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[24]  V. Fuster,et al.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.

[25]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[26]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[27]  P. Balcke,et al.  Incidence of Stroke among Chronic Hemodialysis Patients with Nonrheumatic Atrial Fibrillation , 2001, American Journal of Nephrology.

[28]  T. Akiba,et al.  An Overview of Dialysis Treatment in Japan (as of Dec. 31, 1999) , 2001 .

[29]  D. Feinfeld,et al.  SYMPTOMATIC ATRIAL ARRHYTHMIAS IN HEMODIALYSIS PATIENTS , 2001, Renal failure.

[30]  M. Borrego,et al.  Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. , 2000, American heart journal.

[31]  D. Di Landro,et al.  Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. , 2000, Clinical nephrology.

[32]  E. Ritz,et al.  Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  R. Hart,et al.  Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention , 1999, Annals of Internal Medicine.

[34]  J. Singer,et al.  Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  B. Gersh,et al.  Lone atrial fibrillation: epidemiology and natural history. , 1999, American heart journal.

[36]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[38]  Sílvia Ribeiro,et al.  Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  Y. Yamamoto,et al.  Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  J. Halperin,et al.  Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.

[41]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[42]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[43]  D. Levy,et al.  Impact of Left Ventricular Structure on the Incidence of Hypertension: The Framingham Heart Study , 1994, Circulation.

[44]  K. Iseki,et al.  Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. , 1993, Kidney international.

[45]  M. Rambausek,et al.  Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance. , 1988, Kidney international.

[46]  M. Fujishima,et al.  Incidence of strokes and its prognosis in patients on maintenance hemodialysis. , 1986, Japanese heart journal.

[47]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[48]  R. Garrick.  Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease , 2009 .

[49]  C. Clase,et al.  Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management. , 2006, Thrombosis research.

[50]  P. Raggi.  Cardiovascular calcification in end stage renal disease. , 2005, Contributions to nephrology.

[51]  K. Fushimi,et al.  An Overview of Dialysis Treatment in Japan. , 2001 .

[52]  R. Wolfe,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study , 2000 .

[53]  M. Schlepper,et al.  Cardiac Dysfunction in Patients on Maintenance Hemodialysis , 1986 .

[54]  M. Schlepper,et al.  Cardiac dysfunction in patients on maintenance hemodialysis. I. The importance of associated heart diseases in determining alterations of cardiac performance. , 1986, Contributions to nephrology.